← back to search

Lutz Uharek

Humboldt-Universität zu Berlin · DE
Area of research
Hematology · Immunology
Research interest
Research interests include Hematopoietic Stem Cell Transplantation, Immune Cell Function and Interaction, Acute Myeloid Leukemia Research, and Chronic Lymphocytic Leukemia Research.
h-index
26
citations
3,134
works
133
NIH funding
primary concept
email

Recent publications

Standardized assay for assessment of minimal residual disease in blood, bone marrow and apheresis from patients with plasma cell myeloma
Scientific Reports 2019cited by 15position: lastdoi
Clinical translation and regulatory aspects of CAR/TCR-based adoptive cell therapies—the German Cancer Consortium approach
Cancer Immunology Immunotherapy 2018cited by 15position: middledoi
Epithelial barrier dysfunction as permissive pathomechanism in human intestinal graft-versus-host disease
Bone Marrow Transplantation 2018cited by 5position: middledoi
Allogeneic hematopoietic cell transplantation for high-risk CLL: 10-year follow-up of the GCLLSG CLL3X trial
Blood 2017cited by 76position: middledoi
Treatment of Acute Myeloid Leukemia or Myelodysplastic Syndrome Relapse after Allogeneic Stem Cell Transplantation with Azacitidine and Donor Lymphocyte Infusions—A Retrospective Multicenter Analysis from the German Cooperative Transplant Study Group
Biology of Blood and Marrow Transplantation 2014cited by 200position: middledoi
Tracking in vivo dynamics of NK cells transferred in patients undergoing stem cell transplantation
European Journal of Immunology 2014cited by 28position: middledoi
TP53, SF3B1, and NOTCH1 mutations and outcome of allotransplantation for chronic lymphocytic leukemia: six-year follow-up of the GCLLSG CLL3X trial
Blood 2013cited by 105position: middledoi
Single Nucleotide Polymorphisms Within The Thrombomodulin Gene (THBD) Predict Risk Of Non-Relapse Mortality In Patients With Graft-Versus-Host Disease
Blood 2013cited by 0position: middledoi
Chronic Graft versus Host Disease but not the Intensity of Conditioning has Impact on Survival after Allogeneic Hematopoietic Stem Cell Transplantation for Advanced Hematological Diseases
Onkologie 2012cited by 3position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Michael Stadler · Illinois State University3 papers (2013–2017)Sascha Dietrich · Research Institute of Radiology3 papers (2013–2017)Peter Dreger · Heidelberg Engineering (Germany)3 papers (2013–2017)Norbert Schmitz · University Hospital Münster2 papers (2013–2017)Christof Scheid · TH Köln - University of Applied Sciences2 papers (2013–2017)Stephan Stilgenbauer · Spital STS2 papers (2013–2017)Sebastian Böttcher · University of Lübeck2 papers (2013–2017)Thomas Luft · Heidelberg University2 papers (2013–2014)Michael Kneba · University of Lübeck2 papers (2013–2017)Anthony D. Ho · Mayo Clinic in Arizona2 papers (2013–2017)Michael Hallek · Max Planck Institute for the Study of Societies2 papers (2013–2017)Ute Hegenbart · Centre Hospitalier Universitaire de Poitiers2 papers (2013–2017)Hartmut Döhner · Medizinische Hochschule Hannover2 papers (2013–2017) · 2 papers (2013–2017)Raymonde Busch · Technical University of Munich1 papers (2013–2013)Ulrich Germing · Bristol-Myers Squibb (Switzerland)1 papers (2014–2014)E. Thiel · University of Tübingen1 papers (2012–2012)Thorsten Zenz · Monash University1 papers (2013–2013)Guido Kobbe · Technical University of Munich1 papers (2014–2014)Nicolaus Kröger · Universität Ulm1 papers (2014–2014)